Market Consultation Automated molecular STI diagnostics GGD Amsterdam
GGD Amsterdam is re-tendering the complete package for automated molecular STI diagnostics. The market consultation aims to: (1) determine whether there are multiple suppliers capable of providing a complete, validated system (equipment, software, interfaces, consumables); (2) collect market input regarding possible improvements and innovations for a future procurement. The original solution, implemented in 2018, automatically analyzes STI tests and reports electronically. The new procurement focuses on a complete, integrated package that complies with current laws and regulations, including quality assurance and maintenance. GGD is looking for suppliers with experience in clinical laboratory diagnostics, ISO certification, and data connections with the eHealth network. The market consultation is a first step in a transparent, market-oriented procurement procedure.
Supplies · Marktconsultatie · National procedure
01What is being requested
GGD Amsterdam is re-tendering the complete package for automated molecular STI diagnostics. The market consultation aims to: (1) determine whether there are multiple suppliers capable of providing a complete, validated system (equipment, software, interfaces, consumables); (2) collect market input regarding possible improvements and innovations for a future procurement. The original solution, implemented in 2018, automatically analyzes STI tests and reports electronically. The new procurement focuses on a complete, integrated package that complies with current laws and regulations, including quality assurance and maintenance. GGD is looking for suppliers with experience in clinical laboratory diagnostics, ISO certification, and data connections with the eHealth network. The market consultation is a first step in a transparent, market-oriented procurement procedure.
In 2018, the Regional Laboratory of the Infectious Diseases department of the Municipal Health Service Amsterdam (GGD) conducted a procurement seeking a solution for the provision of automated and validated systems for STI diagnostics, consisting of all necessary equipment and associated hardware and software (including interfaces) and consumables. This solution resulted in a system of automated molecular STI diagnostics that analyzes automated STI tests and reports electronically. GGD Amsterdam will re-tender the complete package of automated molecular STI diagnostics in 2024. Through this m
02Value in context
The contracting authority did not publish an estimated value — common for a large share of contracts. The EU threshold for leveringen is € 221.000, for reference.
03Likely competitors
04Tender documents
05Legal themes that may be relevant here
06Frequently asked questions
What is the purpose of this market consultation?
What is expected of the solution for STI diagnostics?
What kind of system is used in the current working method?
For which activities is the market invited?
Automatically compiled from the official tender data and documents.
07Estimated value versus the market
€ 317K
€ 892K
€ 3,3 mln
Gegunde waarden in CPV 33 · leveringen n=528